Malaria Vaccine 'could be widespread by 2015'
Wednesday, October 09, 2013
![No Image](https://cdn4.premiumread.com/?url=https://www.mmegi.bw/uploads/imported_images/2013/october/09/php6A5E.tmp.jpg&w=400&q=72&f=jpg)
Researchers reported at a malaria conference in Durban, South Africa, that the jab continues to protect a substantial proportion of babies and young children 18 months after vaccination. The mosquito-borne disease kills around 660,000 people every year, most of them children in Sub-Saharan Africa.
British pharmaceutical firm GlaxoSmithKline (GSK), which makes the vaccine, said it would apply for a licence from the European Medicines Agency next year.
These roads, which are vital conduits for trade and tourism, have long been in dire need of repair. However, while this development is undoubtedly a positive step, it also raises questions about broader issues of infrastructural management and road safety that deserve closer scrutiny.The A3 and A33 roads are not just any roads, they are critical arteries that connect Botswana to its neighbours and facilitate the movement of goods and people...